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Abstract
Purpose—To determine the retinal features predictive of progressive stage 4 retinopathy of
prematurity (ROP) after laser treatment for threshold ROP.
Methods—Retrospective review of 72 eyes of 37 infants after laser treatment for threshold ROP
between 1993 and 2002. Retinal features were abstracted from examinations made within 1 week of
development of stage 4A ROP or 2 weeks after laser treatment in eyes with regressed threshold
disease. Predictive features of progressive stage 4 ROP were determined using a generalized
estimating equation model to account for within-subject variability.
Results—The generalized estimating equation showed that vitreous state, ridge elevation of six or
more clock hours, and two or more quadrants of plus disease predicted progressive retinal
detachment, whereas two or more quadrants of neovascularization did not.
Conclusions—Progressive stage 4 ROP requiring surgical intervention was predicted by the
absence of clear vitreous, ridge elevation of six or more clock hours, and two or more quadrants of
plus disease, but not by neovascularization. These results may be useful in the management of eyes
after laser treatment for threshold ROP.
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In eyes that develop progressive stage 4 retinopathy of prematurity (ROP) after laser treatment
for threshold ROP,1,2 vitreoretinal surgery is considered to prevent or repair retinal
detachment.3–7 For the best visual potential, surgery should achieve retinal attachment, be
performed before macular detachment,4 and spare the lens to permit visual rehabilitation in
the phakic eye.3,7 However, surgical complications of cataract,8 aphakia, and peripheral
retinal breaks have vision-threatening consequences, including profound amblyopia and
inoperable retinal detachment,5 which are unique to the developing infant compared with the
adult. In addition, because approximately 70% of eyes treated for threshold ROP1,2 and some
eyes with stage 4A ROP do not progress,9 recognition of retinal features predictive of
progression of stage 4 ROP may facilitate early treatment of eyes at risk for vision loss and
also minimize treatment of some low-risk eyes.
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We performed this study to determine the characteristics predictive of progression of stage 4
ROP in infants who had been adequately treated for threshold ROP. We abstracted features
from retinal drawings made at the time of examinations performed within 1 week of developing
partial retinal detachment (stage 4A ROP) or 2 weeks after laser treatment in eyes that showed
regression of disease. We developed a generalized estimating equation (GEE) model that
accounted for within-subject variability of the eyes10 to determine predictive features of
progressive stage 4 ROP in eyes after laser treatment for threshold ROP.
Methods
Patients and Setting
Thirty-six infants (72 eyes) referred to one physician (M.E.H.) from 1993 to 2002 for
management of stages 3, 4, and 5 ROP were studied. Twenty-one infants (42 eyes) had laser
treatment performed by pediatric ophthalmologists credentialed for the Multicenter Trial of
Cryotherapy for Retinopathy of Prematurity Study (CRYO-ROP) and were referred
specifically for the management of stages 4 and 5 ROP, and 15 infants (30 eyes) had laser and
postlaser management, including surgery performed by the same physician (M.E.H.). All
infants had carefully recorded examinations with retinal drawings before and after laser
treatment for threshold ROP performed by physicians who were credentialed examiners for
the CRYO-ROP study.1 The age when surgery was performed was recorded as postmenstrual
age in weeks (gestational age plus chronologic age). Human subjects’ approval for exempt
status was obtained to gather data retrospectively from patient charts. All patients received full
examinations, including assessment of adequacy of laser treatment and the presence of skip
lesions.
Observation Procedures
The examination sheets, based on forms from the International Classification of Retinopathy
of Prematurity,11 were developed to record retinal features before and after treatment for
threshold ROP. Features were recorded within 1 week of developing partial retinal detachment
(stage 4A ROP) or 2 weeks after laser treatment if regression of ROP occurred. Retinal
characteristics included zone and stage of ROP, vascular engorgement and plus disease, ridge
elevation, vitreous state, and clock hour or quadrant extent of retinal features.1
During the course of the study, surgical management developed and changed. To ensure
uniformity for feature abstraction for every infant, sequential weekly examination forms were
available for all study infants. Thus, for infants who had developed stage 4 or 5 ROP,
retrospective retrieval of feature data was possible within 1 week of development of retinal
detachment regardless of the stage at which the surgery was ultimately performed. Data within
1 week of stage 4A ROP was collected when possible, unless progression to stage 4B ROP
occurred between two sequential weekly examinations. Uniformity of feature abstraction also
applied to infants who developed stage 4 ROP and had regression without need for surgical
intervention and for infants who had regressed threshold ROP without developing retinal
detachment. For infants who had regression of threshold ROP, however, we chose the time of
2 weeks after laser treatment to abstract features for analysis. Features of all infants were
available from records except for two eyes of one infant (Table 1), whose examination report
lacked the number of quadrants of plus disease 1 week before developing stage 4 ROP; this
was accounted for in the statistical analysis. The indication for surgery was progressive stage
4 ROP threatening the macula. All infants were followed up for 4 months after laser treatment
to detect late development of stage 4 or 5 ROP.
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Ridge elevation was defined as per the International Classification of Retinopathy of
Prematurity,11 a thickened structure arising from the retinal surface at the junction of the
avascular and vascularized retina. Ridge elevation was considered independent from
neovascularization or retinal detachment. When ridge elevation, retinal detachment (retinal
elevation between the ridge and optic nerve), or neovascularization was present at the same
time, each was noted separately. Ridge elevation was observed to be new if flattening of the
ridge was observed after laser treatment and then recurred, or to be persistent if ridge elevation
remained for longer than 2 weeks after laser treatment. Ridge elevation and its clock hour extent
were recorded for every eye. The status of the vitreous was graded from 0 to 4 (0, clear; 1,
hazy; 2, limited hemorrhage obscuring part of the ridge; 3, hazy vitreous and grade 2
hemorrhage; and 4, organization of vitreous with evidence of condensation within the vitreous
cavity). Plus disease was recorded as the number of retinal quadrants in which the dilated retinal
arteries and veins were observed. When the retinal veins were dilated in one quadrant but the
arteries appeared normal, the feature was recorded as half a quadrant of vascular dilatation.
The quadrants of pre-retinal neovascularization were also recorded.
Statistical Analysis
Statistical Analysis System (SAS Institute, Cary, NC) was used for analyses, including a GEE
model that accounted for within-subject variability of the eyes.10 The outcome was progression
to retinal detachment requiring surgery and the predictor variables were vitreous score, clock
hours of ridge elevation, and quadrants of plus disease and neovascularization. All P values
given for predictors in the GEE model are from Wald statistics on the model parameters.12
Odds ratios (OR) were determined from the GEE model parameters, and 95% confidence
intervals (CIs) are given.
Results
Patients
This study included 72 eyes (36 right eyes and 36 left eyes) of 36 infants (13 girls and 23 boys).
The median birthweight was 670 g (interquartile range [IQR], 613–748 g), and the median
gestational age was 24 weeks (IQR, 24–25 weeks). In all but one eye that developed vitreous
hemorrhage before threshold ROP, previous laser treatment for threshold ROP was performed
as recommended.1,2 Except for two infants (four eyes) treated with cryotherapy in addition to
laser, all infants were treated with laser only. No apparent skip lesions in laser treatment were
noted in any eye. All eyes, except one, that developed stage 4A ROP did so 2 or more weeks
after laser treatment. In the one exception, the infant developed a stage 4B tractional retinal
detachment within 1 week of laser treatment.
Features
Table 1 lists the number and frequency of retinal features and progression to retinal detachment
or regression of disease. In both eyes of one patient, an assessment of plus disease could not
be made from the records.
Thirty-four eyes developed progressive stage 4 ROP and required surgery, whereas 38 eyes
showed regression of stage 3 (32 eyes) or 4 (six eyes) ROP. Because of the referral nature of
the practice, the frequency of retinal detachment was higher than that reported in other studies.
1,2 For example, some patients who received laser treatment by outside ophthalmologists were
never referred because threshold disease regressed without the development of stage 4 ROP.
Twelve infants required surgery in both eyes, 10 in one eye only, and 14 in neither eye. Ridge
elevation occurred in 34 eyes that required surgery, compared with 18 eyes that did not
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progress. Of those eyes with ridge elevation that required surgery, 74% (26 of 34) had six or
more clock hours of ridge elevation, whereas in eyes with regressed ROP, only three (8%) of
38 eyes had six or more clock hours of ridge elevation.
We used a GEE model that included within-subject assessment of variance. Features present
after laser treatment for threshold ROP that predicted progression to retinal detachment
requiring surgical intervention were six or more clock hours of ridge elevation (P = 0.0248),
absence of clear vitreous on examination (P = 0.0039), and two or more quadrants of plus
disease (P = 0.0490). OR estimates were six or more clock hours of ridge elevation (OR =
33.6; 95% CI, 1.56–722.9), absence of clear vitreous on examination (OR = 32.6; 95% CI, 3.1–
347.8), two or more quadrants of plus disease (OR = 4.95; 95% CI, 1.01–24.34).
Neovascularization in two or more quadrants extent was not a significant predictor (P =
0.9609). Fewer clock hours of ridge elevation or variations in the number of quadrants of plus
disease or neovascularization were not significant.
Discussion
Early surgical intervention in stage 4 ROP can be critical to preserve vision for certain eyes,
but there are few specific guidelines to determine eyes at risk of progressive ROP after laser
treatment for threshold disease.1–3,7,13 We studied retinal features that confront the
ophthalmologist monitoring eyes after laser treatment for threshold ROP. These features were
recorded within 1 week of the development of stage 4A ROP or 2 weeks after laser treatment
in eyes that showed regression of threshold ROP. The outcome was progression of stage 4 ROP
requiring surgery for threatened macular detachment. Features that predicted progressive stage
4 ROP were absence of clear vitreous, plus disease in two or more quadrants, and six or more
clock hours of ridge elevation. Neovascularization or fewer than six clock hours of ridge
elevation or two quadrants of plus disease were not predictive of disease progression.
As with any retrospective study, potential flaws exist. First, data abstraction from drawings
can result in data error because of differences in interpretation of an image by the same observer
or multiple observers. However, feature detection from fundus drawings of infants has been
the standard in large multicenter clinical trials for ROP,1,2 and all drawings in our study were
performed by ophthalmologists credentialed for the CRYO-ROP study. Second, sometimes
features may not be recorded with sufficient detail to be analyzed. In our study, only one infant
examination (two eyes) (Table 1) lacked sufficient information about one feature (i.e., the
number of quadrants of plus disease) and was accounted for in the GEE. Third, many
retrospective studies present only case series. This study, though retrospective, did provide a
reasonable control group for comparison, namely infants who received laser treatment for
threshold ROP, were diagnosed and treated by ophthalmologists credentialed for the CRYO-
ROP study, and had regression of threshold disease. The controls were also not historic, in that
they were selected from the same period as the study group, thus reducing possible error
associated with changes in management. Finally, most studies of stage 4 ROP fail to consider
the effect of within-subject variability of the eyes, thereby adding error to the analysis of infants
with ROP, because of the high correlation in disease severity between eyes.14 To avoid this,
we used a GEE model to account for within-individual variability and included infants who
had received laser treatment in both eyes for threshold ROP.15 We found significance, although
the small numbers provided wide confidence intervals.
The causes of these late-onset features predictive of retinal detachment are unknown. There is
evidence that increased vitreous haze may occur from breakdown of the blood–retina barrier
related to vascular endothelial growth factor–induced permeability.16 Several growth factors,
including vascular endothelial growth factor, platelet-derived growth factor, and hepatocyte
growth factor,17 induce cell proliferation and migration18 and may promote the thickening of
HARTNETT and MCCOLM Page 4













the ridge. Cell proliferation and migration onto the ridge and into the vitreous can produce
visible vitreous membranes connecting the peripheral retina to anterior ocular structures. Later
contraction of these membranes would detach the peripheral retina. We found that fewer than
six clock hours of ridge elevation did not predict progressive retinal detachment. Perhaps when
the process of vitreoretinal contraction is limited in clock hour extent, the forces acting to
detach the retina are offset by the forces to maintain retina attachment.
Possible factors contributing to plus disease are also complex and may involve those that affect
vascular diameter and blood flow,19 such as nitric oxide20 and endothelin-1.21 That
neovascularization was not predictive of retinal detachment is contrary to current clinical
expectations. Our findings may indicate that changes that occur to neovascularization after
laser treatment, such as early regression, may not be apparent by clinical observation alone.
Regardless of the reasons, neovascularization after adequate laser treatment, without skip
lesions, was an insensitive clinical marker for progression of retinal detachment in this study.
This retrospective study provides statistical support regarding guidelines for eyes at risk for
progressive stage 4 ROP after treatment for threshold disease. It also provides pilot data for a
large, prospective, multicenter study to assess anatomic and visual outcomes in stage 4 ROP
and include an analysis of retinal features after laser treatment for threshold ROP that were
predictive of progressive retinal detachment. Guidelines from such a study would aid in
determining the timing of surgery for stage 4 ROP and would facilitate and improve the clinical
management of infants with ROP.
From our study, we provide evidence that features of hazy vitreous, plus disease in two or more
quadrants, and ridge elevation of six or more clock hours may herald the need for surgical
intervention for retinal detachment in ROP. We did not find a predictive value of progressive
retinal detachment from ridge elevation of fewer than six clock hours, plus disease in fewer
than two quadrants, or neovascularization.
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Table 1
Retinal Features of Retinopathy of Prematurity in Eyes that Regressed or that Required Surgical Intervention




 <2 quadrants 7 (10) 28 (39)
 ≥2 quadrants 25 (35) 10 (14)
Vitreous state (score)
 Clear (0) 8 (11) 35 (49)
 Hazy +/or vitreous hemorrhage (1, 2, 3) 15 (21) 2 (3)
 Obvious organization of vitreous (4) 11 (15) 1 (1)
Ridge elevation
 <6 clock hours 9 (12) 35 (49)
 ≥6 clock hours 25 (35) 3 (4)
Neovascularization
 <2 quadrants 13 (18) 34 (47)
 ≥2 quadrants 21 (29) 4 (6)
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